HSTO logo

Histogen (HSTO) EBIT

Annual EBIT

-$10.64 M
+$4.36 M+29.04%

December 31, 2022


Summary


Performance

HSTO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSTOprofitabilitymetrics:

Quarterly EBIT

-$3.85 M
-$1.77 M-84.58%

September 30, 2023


Summary


Performance

HSTO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSTOprofitabilitymetrics:

TTM EBIT

-$12.38 M
-$256.00 K-2.11%

September 30, 2023


Summary


Performance

HSTO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSTOprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

HSTO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.0%-7.1%-14.4%
3 y3 years-895.6%-15.2%-15.4%
5 y5 years-895.6%-126.8%-107.3%

HSTO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+29.0%-464.3%at low-16.4%+17.4%
5 y5-year-895.6%+43.3%-464.3%+63.5%-107.3%+44.7%
alltimeall time-895.6%+43.3%-464.3%+63.5%-628.9%+44.7%

Histogen EBIT History

DateAnnualQuarterlyTTM
Sep 2023
-
-$3.85 M(+84.6%)
-$12.38 M(+2.1%)
Jun 2023
-
-$2.09 M(-39.9%)
-$12.13 M(-9.7%)
Mar 2023
-
-$3.47 M(+17.0%)
-$13.43 M(+26.2%)
Dec 2022
-$10.64 M(-29.0%)
-$2.97 M(-17.5%)
-$10.64 M(-1.7%)
Sep 2022
-
-$3.60 M(+6.0%)
-$10.83 M(-2.3%)
Jun 2022
-
-$3.39 M(+396.9%)
-$11.09 M(-2.8%)
Mar 2022
-
-$683.00 K(-78.3%)
-$11.41 M(-23.9%)
Dec 2021
-$15.00 M
-$3.15 M(-18.3%)
-$15.00 M(-33.0%)
Sep 2021
-
-$3.86 M(+3.7%)
-$22.39 M(+2.3%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$3.72 M(-13.0%)
-$21.88 M(+3.4%)
Mar 2021
-
-$4.27 M(-59.5%)
-$21.17 M(+12.9%)
Dec 2020
-$18.75 M(+1654.3%)
-$10.55 M(+215.2%)
-$18.75 M(+74.7%)
Sep 2020
-
-$3.35 M(+11.3%)
-$10.73 M(+17.5%)
Jun 2020
-
-$3.01 M(+62.1%)
-$9.13 M(+16.7%)
Mar 2020
-
-$1.85 M(-26.7%)
-$7.83 M(+31.0%)
Dec 2019
-$1.07 M
-$2.53 M(+44.8%)
-$5.97 M(+73.4%)
Sep 2019
-
-$1.75 M(+2.8%)
-$3.44 M(+102.8%)
Jun 2019
-
-$1.70 M
-$1.70 M

FAQ

  • What is Histogen annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Histogen?
  • What is Histogen annual EBIT year-on-year change?
  • What is Histogen quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Histogen?
  • What is Histogen quarterly EBIT year-on-year change?
  • What is Histogen TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Histogen?
  • What is Histogen TTM EBIT year-on-year change?

What is Histogen annual earnings before interest & taxes?

The current annual EBIT of HSTO is -$10.64 M

What is the all time high annual EBIT for Histogen?

Histogen all-time high annual earnings before interest & taxes is -$1.07 M

What is Histogen annual EBIT year-on-year change?

Over the past year, HSTO annual earnings before interest & taxes has changed by +$4.36 M (+29.04%)

What is Histogen quarterly earnings before interest & taxes?

The current quarterly EBIT of HSTO is -$3.85 M

What is the all time high quarterly EBIT for Histogen?

Histogen all-time high quarterly earnings before interest & taxes is -$683.00 K

What is Histogen quarterly EBIT year-on-year change?

Over the past year, HSTO quarterly earnings before interest & taxes has changed by -$256.00 K (-7.12%)

What is Histogen TTM earnings before interest & taxes?

The current TTM EBIT of HSTO is -$12.38 M

What is the all time high TTM EBIT for Histogen?

Histogen all-time high TTM earnings before interest & taxes is -$1.70 M

What is Histogen TTM EBIT year-on-year change?

Over the past year, HSTO TTM earnings before interest & taxes has changed by -$1.56 M (-14.38%)